Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

News SummaryMost relevantAll newsSector news 
The feature you requested does not exist. However, we suggest the following feature:

Vertex Pharmaceuticals : Assigned Patent

11/27/2015 | 07:08am US/Eastern

By Targeted News Service

ALEXANDRIA, Va., Nov. 27 -- Vertex Pharmaceuticals, Boston, has been assigned a patent (9,193,722) developed by 12 co-inventors for "tri-cyclic pyrazolopyridine kinase inhibitors." The co-inventors are Juan-Miguel Jimenez, Abingdon, United Kingdom, John Studley, Abingdon, United Kingdom, Ronald Knegtel, Abingdon, United Kingdom, Luca Settimo, Abingdon, United Kingdom, Christopher John Davis, Abingdon, United Kingdom, Damien Fraysse, Abingdon, United Kingdom, Philip N. Collier, Arlington, Massachusetts, Guy Brenchley, Abingdon, United Kingdom, Dean Boyall, Abingdon, United Kingdom, Andrew Miller, Abingdon, United Kingdom, Heather Twin, Abingdon, United Kingdom, and Stephen Young, Abingdon, United Kingdom.

The patent application was filed on April 30, 2013 (13/873,591). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=9,193,722.PN.&OS=PN/9,193,722&RS=PN/9,193,722

Written by Amal Ahmed; edited by Jaya Anand.

AM1127JA1127-1142931 93JAnand

(c) 2015 Targeted News Service, source News Service

React to this article
07:08a VERTEX PHARMACEUTICALS : Assigned Patent
11/25 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® lumacaftor/ivacaftor,..
11/25 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® ivacaftor for P..
11/23 VERTEX PHARMACEUTICALS : to Present at the Piper Jaffray Healthcare Conference o..
11/23 VERTEX PHARMACEUTICALS : EC grants marketing authorisation for Vertex's ORKAMBI ..
11/23 VERTEX PHARMACEUTICALS : Appoints Michael J. Parini as Executive Vice President ..
11/20 VERTEX PHARMACEUTICALS : Receives EU Approval for ORKAMBI® (lumacaftor/ivacaftor..
11/18 VERTEX PHARMACEUTICALS : Receives Two EU Approvals for KALYDECO® (ivacaftor) for..
11/13 VERTEX PHARMACEUTICALS : Assigned Patent
11/12 VERTEX PHARMACEUTICALS : Goldberg Law PC Announces an Investigation of Claims ag..
News chart
Full-screen chart
Income Statement Evolution
More Financials